Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation

Figure 1 Spleen size, body mass index, and hepatic steatosis. A: Spleen longitudinal diameter (SLD) in the psoriatic patients and obese controls; B: Prediction of body mass index (BMI) on SLD of patients with psoriasis (dotted lines near the regression line are the 95% confidence curves, the far ones are the 95% prediction curves); C: SLD in overweight/obese psoriatic patients (O/O) and normal weight (NW) psoriatic patients; D: Hepatic steatosis (HS) grade in patients (cases) and controls: grade 0 = absent; 1 = mild; 2 = moderate; 3 = severe. Boxes in A, C and D indicate the interquartile ranges and the transverse lines represent the median.